Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Nanomaterials for medical diagnosis and therapy
2007
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
MYC on the Path to Cancer
2012 Standout
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate
1998
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Energy metabolism in tumor cells
2007
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
2006
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
INDICATIONS FOR PELVIC LYMPHADENECTOMY IN PROSTATE CANCER
2001
Targeted therapy in rare cancers—adopting the orphans
2012
Incidence of soft tissue sarcoma and beyond
2012
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Celiac Disease
2007 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Inflammatory Bowel Disease
1991 Standout
Aerobic Glycolysis by Proliferating Cells: Protection against Oxidative Stress at the Expense of Energy Yield
1997
Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity
1991
Spatial Charge Configuration Regulates Nanoparticle Transport and Binding Behavior In Vivo
2012 StandoutNobel
Regulation of cancer cell metabolism
2011 Standout
Human papillomavirus and cervical cancer
2007 Standout
Targeting aspartate aminotransferase in breast cancer
2008
The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy
1997
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
A Comparison of Suture Repair with Mesh Repair for Incisional Hernia
2000 Standout
Small-scale systems for in vivo drug delivery
2003
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
2006
Oncogenic alterations of metabolism
1999 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer
2002
Cancer of the Ovary
2004 Standout
Risk factors for rapid-onset cervical cancer
1999
Drug effects on the liver
1979
Impact of Nanotechnology on Drug Delivery
2009 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group
1982
Drug effects on the liver
1983
The Outcomes of Nonabsorbable Mesh Placed Within the Abdominal Cavity: Literature Review and Clinical Experience
1998
8 Malignant lymphoma in the elderly
1987
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Ovarian cancer statistics, 2018
2018 Standout
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.
1986
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Nanoscale theranostics for physical stimulus-responsive cancer therapies
2015
Activation of stratospheric chlorine by reactions in liquid sulphuric acid
1994 StandoutNobel
Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1
1997
Prognostic Factors in Men with Stage D1 Prostate Cancer: Identification of Patients Less Likely to Have Prolonged Survival After Radical Prostatectomy
1994
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis
1987
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic Readiness
2015 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Recent Developments in Nonspecific Inflammatory Bowel Disease
1982
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center
2000
Endometrial Carcinoma
1996
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of Charles E. Platz being referenced
Female genital tract cancer
1995
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository
2013
Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis
2002
Use of Permanent Interstitial Temperature Self-Regulating Rods for Ablation of Prostate Cancer
2000
Isozyme patterns of normal, benign, and malignant human breast tissues.
1983
Desmoid Tumors of the Abdominal Wall
1976
Enzyme activities in normal, dysplastic, and cancerous human breast tissues.
1984
Fatal Halothane Hepatitis with Transient Granulomas
1970
Cryosurgery in prostatic cancer: Elimination of local lesion
1983
The Frozen Section in Lymphadenectomy for Carcinoma of the Prostate
1984
The Occurrence of Rare Cancers in U.S. Adults, 1995–2004
2010
Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)
1982
Multicentric colonic lymphoma complicating ulcerative colitis
1977
Small Intestinal Cancer: a Population-Based Study of Incidence and Survival Patterns in the United States, 1992 to 2006
2010
Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma
1979
Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung
1984